XSHG
603368
Market cap903mUSD
Oct 09, Last price
15.48CNY
1D
1.71%
1Q
1.31%
Jan 2017
-51.07%
IPO
-5.05%
Name
Guangxi LiuYao Group Co Ltd
Chart & performance
P/E
8.67
P/S
0.29
EPS
1.79
Div yield, %
4.93%
Shrs. gr., 5y
1.84%
Rev. gr., 5y
5.96%
Revenues
20.93b
-1.21%
Net income
709m
-17.01%
CFO
1.08b
+28.52%
Dividend
Jun 16, 20260.68 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Guangxi LiuYao Group Co., Ltd., a company established in 1981 and headquartered in Liuzhou, China, focuses on the wholesale and retail of pharmaceutical goods across the Chinese market. Furthermore, it operates as a subsidiary of Liuzhou Liangmianzhen Co., Ltd.
Key people
Chaoyang Zhu
Chairman of the Board, President · since 2023
Zhen Liang
Vice President · since 2024
Chunxue Tang
Vice President, Director · since 2023
Xianrong Tang
Vice President · since 2023
Junxiong Xiao
Vice President · since 2023
Xiangxing Zeng
Chief Financial Officer, Vice President · since 2023
Wenjie Shen
Vice President, Secretary of the Board · since 2023
Hong Chen
Director · since 2024
Xianhua Zhu
Vice President, Director · since 2024
Yanmao Huang
Independent Director · since 2023
Nianyi Ma
Independent Director · since 2023
Jianhong Tao
Independent Director · since 2023
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||